TrialBlood advances2021

Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study.

Evangelos Terpos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.